IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.522
EU - Europa 1.561
AS - Asia 1.531
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 33
OC - Oceania 7
Totale 6.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.423
SG - Singapore 715
IT - Italia 328
IE - Irlanda 255
UA - Ucraina 218
HK - Hong Kong 210
RU - Federazione Russa 206
BR - Brasile 205
CN - Cina 205
SE - Svezia 183
VN - Vietnam 174
FI - Finlandia 86
DE - Germania 82
FR - Francia 79
GB - Regno Unito 44
IN - India 38
CA - Canada 37
BD - Bangladesh 33
TR - Turchia 27
AR - Argentina 24
KR - Corea 22
PK - Pakistan 17
AT - Austria 13
IQ - Iraq 13
CO - Colombia 12
CR - Costa Rica 12
MX - Messico 11
UZ - Uzbekistan 11
VE - Venezuela 11
CH - Svizzera 10
ID - Indonesia 10
NL - Olanda 10
BE - Belgio 8
PL - Polonia 8
ZA - Sudafrica 8
EC - Ecuador 7
JP - Giappone 7
CW - ???statistics.table.value.countryCode.CW??? 6
GT - Guatemala 6
IL - Israele 6
JO - Giordania 6
TN - Tunisia 6
ES - Italia 5
JM - Giamaica 5
NI - Nicaragua 5
PH - Filippine 5
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
GP - Guadalupe 3
GR - Grecia 3
HN - Honduras 3
LB - Libano 3
LT - Lituania 3
SV - El Salvador 3
TH - Thailandia 3
AU - Australia 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
ME - Montenegro 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MG - Madagascar 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
Totale 5.926
Salva come PNG Salva come JPEG
Città #
Singapore 495
Chandler 295
Dublin 254
San Jose 244
Hong Kong 207
Ashburn 201
San Mateo 140
Jacksonville 137
Dong Ket 107
Santa Clara 102
Altamura 91
Boardman 91
Council Bluffs 88
Princeton 70
Medford 69
Beijing 67
Lawrence 67
Moscow 63
Lauterbourg 60
Wilmington 57
Perugia 48
New York 36
Los Angeles 27
Ann Arbor 24
Ho Chi Minh City 24
Rome 24
Helsinki 23
Seoul 22
Andover 21
São Paulo 20
Naples 17
The Dalles 17
Hanoi 16
Saint Petersburg 16
Des Moines 15
North Bergen 15
Phoenix 14
Brooklyn 12
Atlanta 11
Izmir 11
Milan 11
Norwalk 11
San José 11
Chennai 10
Chicago 10
Denver 9
Falls Church 9
Montreal 9
Munich 9
Rio de Janeiro 9
San Paolo di Civitate 9
Shanghai 9
Amsterdam 8
Bologna 8
Redwood City 8
Toronto 8
Belo Horizonte 7
Dallas 7
Amman 6
Brussels 6
Columbus 6
Guatemala City 6
Piscataway 6
Tokyo 6
Willemstad 6
Woodbridge 6
Baghdad 5
Cagliari 5
Frankfurt am Main 5
Johannesburg 5
Lahore 5
London 5
Managua 5
Mexico City 5
Ottawa 5
Porto Alegre 5
San Francisco 5
Seattle 5
Tashkent 5
Vienna 5
Warsaw 5
Amelia 4
Ankara 4
Caxias do Sul 4
Florence 4
Goiânia 4
Houston 4
Karachi 4
Manchester 4
Miami 4
New Delhi 4
Nuremberg 4
Orem 4
Palermo 4
Queens 4
San Diego 4
Asunción 3
Bari 3
Bauru 3
Bogotá 3
Totale 3.675
Salva come PNG Salva come JPEG
Nome #
Prehypertension and Cardiometabolic Syndrome 156
Adverse prognostic significance of new diabetes in treated hypertensive subjects 133
Aliskiren versus ramipril in hypertension. 126
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 119
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 115
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 113
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 112
Above which blood pressure level does the risk of atrial fibrillation increase? 112
Microalbuminuria and hypertension. 111
Improved cardiovascular risk stratification by a simple ECG index in hypertension 109
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 107
New-onset diabetes, antihypertensive treatment, and outcome 104
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 104
Angiotensin-converting enzyme inhibitors 104
Optimal therapy in hypertensive subjects with diabetes mellitus 103
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 101
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 100
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 99
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 98
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 95
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 94
Angiotensin receptor blockers in hypertension. New insights from Japan. 93
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 93
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 93
Blood pressure lowering in diabetic patients. 92
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 92
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 91
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 90
Telmisartan for the reduction of cardiovascular morbidity and mortality. 90
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 89
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 89
New-onset diabetes in treated hypertensive patients 89
Comparative assessment of angiotensin receptor blockers in different clinical settings. 88
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 88
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 87
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 87
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 87
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 87
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 84
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 84
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 82
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 80
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 78
Modernization and hypertension: is the link changing? 78
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 78
Perioperative beta blockade: the debate continues. 76
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 76
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 76
White-coat hypertension in adults. 74
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 74
Statins in acute coronary syndrome: very early initiation and benefits. 73
Diuretic treatment of hypertension 73
Fixed-dose combination therapy in hypertension: cons. 72
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 70
Good news for beta-blockers in perioperative medicine. 68
Hypertension around the world: new insights from developing countries. 67
Prognostic value of lipoprotein fractions in essential hypertension. 64
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 64
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 63
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 62
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 62
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 59
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 59
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 59
Protein intake in type 1 diabetes: putting controversies into perspectives. 59
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 59
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 58
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 56
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 53
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 50
Totale 6.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 0 0 0 0 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025765 4 76 29 51 105 35 50 34 146 42 151 42
2025/20261.731 118 115 120 181 236 138 336 99 178 126 69 15
2026/2027751 38 66 148 446 53 0 0 0 0 0 0 0
Totale 6.030